1Brownlee M, Rami A, Vlassara H. Advanced glacosylation end - products in tissue and the biochemical basis of diabetic comlications. N Engl J Med, 1998,318:1315～1321
3Inagi R Miyata T. Oxidative protein danage with carbohydrates and lipids in themia :carborryl atress. Blood pttrif,1999:17(2- 3) :95～8
4Chappey O, Dosquct C, Wautier MP, et al. Advanced glycation end products, oxidant stress and vascluar lesions,J Chin-Invest 1997,27(2) :97～108
5Mene P, Pascale C, Teti A, et al. Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells. JAm Soc Nephrol, 1999,10(7):1478～86
6Uesugi N, Sakata N, Nagai R et al. Glycoxidative modification of AA amyloid deposits in renal tissue.Nephrol Dial Tansplant, 2000,15 (3):355～65
7Min C, Kang E, Yu SH, et al. Advanced glycation end products induce apoptosis and procoagulant activity in cultured human umbilical vein endothelial cells. Diabetes Res Clin Pract, 1999,46 (3):197～202
8Bach LA, Dean R, Youssef S, et al. Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathy. Nephrol Dial Transplant, 2000, 15(3):347～54
9Ruggiero -Lopez D,Lecomte M,Moinet G,et al. Reaction of metformin with dicarbonyl compounds. possible implication in the inhibition of advanced glycation end product formation. Biochem Pharmacol 1999,58(11):1765～73
10Jakns V. Hrnciarova M. Carsky J, et al. Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activity Life Sci, 1999, 65 (18-19):1991
